Mira Pharmaceuticals Inc (NASDAQ: MIRA) has seen a decline in its stock price by -5.24 in relation to its previous close of 2.10. However, the company has experienced a -5.24% decline in its stock price over the last five trading sessions. accesswire.com reported 2024-08-12 that This breakthrough in bioavailability and formulation showcases the potential for advanced, at home neurological treatments. MIAMI, FL / ACCESSWIRE / August 12, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), or MIRA Pharmaceuticals, a leading pre-clinical-stage pharmaceutical company unveiled new preclinical data providing further insights into the mechanism of action of its innovative drug candidate, Ketamir-2’s principal metabolite, Nor-Ketamir-2.
Is It Worth Investing in Mira Pharmaceuticals Inc (NASDAQ: MIRA) Right Now?
Company’s 36-month beta value is 4.02.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for MIRA is 9.52M, and currently, short sellers hold a 4.70% ratio of that floaft. The average trading volume of MIRA on August 12, 2024 was 4.91M shares.
MIRA’s Market Performance
MIRA’s stock has seen a -5.24% decrease for the week, with a 237.75% rise in the past month and a 176.39% gain in the past quarter. The volatility ratio for the week is 12.93%, and the volatility levels for the past 30 days are at 39.25% for Mira Pharmaceuticals Inc The simple moving average for the past 20 days is -4.19% for MIRA’s stock, with a 49.80% simple moving average for the past 200 days.
MIRA Trading at 59.54% from the 50-Day Moving Average
After a stumble in the market that brought MIRA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -71.80% of loss for the given period.
Volatility was left at 39.25%, however, over the last 30 days, the volatility rate increased by 12.93%, as shares surge +179.73% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +158.75% upper at present.
During the last 5 trading sessions, MIRA fell by -1.43%, which changed the moving average for the period of 200-days by -17.20% in comparison to the 20-day moving average, which settled at $2.14. In addition, Mira Pharmaceuticals Inc saw 89.52% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MIRA starting from Aminov Erez, who purchase 8,700 shares at the price of $0.94 back on May 21 ’24. After this action, Aminov Erez now owns 382,200 shares of Mira Pharmaceuticals Inc, valued at $8,176 using the latest closing price.
McNulty Brian Patrick, the 10% Owner of Mira Pharmaceuticals Inc, sale 46,005 shares at $1.55 during a trade that took place back on Dec 11 ’23, which means that McNulty Brian Patrick is holding 660,000 shares at $71,496 based on the most recent closing price.
Stock Fundamentals for MIRA
The total capital return value is set at -2.84. Equity return is now at value -1807.80, with -587.64 for asset returns.
Based on Mira Pharmaceuticals Inc (MIRA), the company’s capital structure generated 0.0 points at debt to capital in total, while cash flow to debt ratio is standing at -4404.34. The debt to equity ratio resting at 0.0. The interest coverage ratio of the stock is -2.55.
Currently, EBITDA for the company is -8.53 million with net debt to EBITDA at 0.39. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.70.
Conclusion
In a nutshell, Mira Pharmaceuticals Inc (MIRA) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
